Company profile for Viridian Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Viridian Sciences is the right software platform for your Cannabusiness. With your investment in the Viridian Sciences software solution, it is understood and expected that you will have questions outside of the pre & post go-live phases of your implementation. With our goal to provide the best customer care and support in the industry, Viridian Sciences is pleased to offer enhanced Customer Care & Support focused on deliverin...
Viridian Sciences is the right software platform for your Cannabusiness. With your investment in the Viridian Sciences software solution, it is understood and expected that you will have questions outside of the pre & post go-live phases of your implementation. With our goal to provide the best customer care and support in the industry, Viridian Sciences is pleased to offer enhanced Customer Care & Support focused on delivering world-class customer

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
170 S Main St, Pleasant Grove, UT 84062
Telephone
Telephone
(385) 323-9115
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2021/11/15/2334093/31683/en/Viridian-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-VRDN-001-an-IGF-1R-Antibody-for-the-Treatment-of-Thyroid-Eye-Disease-TED.html

GLOBENEWSWIRE
15 Nov 2021

https://www.globenewswire.com/news-release/2021/09/30/2306164/0/en/Viridian-Therapeutics-to-Present-Preclinical-Data-on-VRDN-001-and-VRDN-002-at-the-90th-Annual-Meeting-of-the-American-Thyroid-Association.html

GLOBENEWSWIRE
30 Sep 2021

https://www.globenewswire.com/news-release/2021/09/20/2300096/31683/en/Viridian-Therapeutics-Announces-Proposed-Underwritten-Public-Offering-of-Common-Stock-and-Preferred-Stock.html

GLOBENEWSWIRE
20 Sep 2021

https://www.globenewswire.com/news-release/2021/08/05/2275635/31683/en/Viridian-Therapeutics-to-Participate-in-the-Wedbush-PacGrow-Healthcare-Virtual-Conference.html

GLOBENEWSWIRE
05 Aug 2021

https://www.globenewswire.com/news-release/2021/07/14/2262736/31683/en/Viridian-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
14 Jul 2021

https://www.globenewswire.com/news-release/2021/07/07/2258927/31683/en/Viridian-Therapeutics-to-Present-at-the-Ladenburg-Thalmann-2021-Healthcare-Conference.html

GLOBENEWSWIRE
07 Jul 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty